Oral presentation to detail safety and efficacy of PSMA-targeted actinium-225 (Ac-225) radioantibodyCAMBRIDGE, Mass.--(BUSINESS WIRE)--Convergent Therapeutics Inc., a clinical-stage biotechnology ...

American Urological Association Releases Clinically Localized Prostate Cancer Guideline Amendment Today, the American ...

From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...

The Barbara Ann Karmanos Cancer Institute has expanded access of three groundbreaking cancer therapies to Karmanos Cancer Network locations in Michigan. As part of Karmanos' theranostics program, ...

Radium-223 retains a role in osteoblastic bone-only disease, while PSMA PET has become indispensable across staging, ...

Lutetium PSMA is administered via a drip and travels through the bloodstream seeking out prostate cancer cells before hitting them with targeted internal radiation, the University Hospitals Sussex NHS ...

Michael Platts panicked when he was diagnosed with prostate cancer. Now he wants to help others break through the stigma and ...

The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...

The Barbara Ann Karmanos Cancer Institute in Detroit has expanded access to three radiopharmaceutical cancer therapies to Karmanos Cancer Network locations in Michigan.

India, April 2 -- Men with early-stage metastatic prostate cancer may soon be able to postpone the debilitating side effects of hormone therapy through targeted internal radiotherapy.(1) ...